Grete Hogstad
Vendite & Marketing presso PHOTOCURE ASA
Patrimonio netto: 153 399 $ in data 30/04/2024
Posizioni attive di Grete Hogstad
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PHOTOCURE ASA | Vendite & Marketing | 01/02/2005 | - |
Association for Accessible Medicines
 Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Corporate Officer/Principal | - | - |
Storia della carriera di Grete Hogstad
Precedenti posizioni note di Grete Hogstad
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Xellia Pharmaceuticals AS
 Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway. | Vendite & Marketing | - | - |
| Alpharma, Inc. /Active Pharmaceutical Ingredients/ | Vendite & Marketing | - | - |
| NAVAMEDIC ASA | Direttore/Membro del Consiglio | 18/06/2010 | - |
Formazione di Grete Hogstad
| University of Oslo | Undergraduate Degree |
| BI Norwegian Business School | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Norvegia | 7 |
| Stati Uniti | 2 |
Posizioni
| Sales & Marketing | 3 |
| Undergraduate Degree | 2 |
| Director/Board Member | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PHOTOCURE ASA | Health Technology |
| NAVAMEDIC ASA | Distribution Services |
| Aziende private | 3 |
|---|---|
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
| Alpharma, Inc. /Active Pharmaceutical Ingredients/ | Health Technology |
Xellia Pharmaceuticals AS
Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway. | Health Technology |
- Borsa valori
- Insiders
- Grete Hogstad
- Esperienza
